Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OBS Medical, a developer of clinical solutions for safer hospitals, safer patients and safer drugs, has announced that the FDA has granted 510(k) clearance for the company to market its Visensia Alert in the US.
Subscribe to our email newsletter
Formerly know as BioSign, Visensia’s automated early warning technology fuses up to five vital signs – heart rate, respiration rate, body temperature, oxygen saturation and blood pressure – into a numerical index.
According to the company, the Visensia index is an indication of a patient’s wellness and can enable significant improvement in clinical outcomes and optimization of hospital resource utilization. When the index reaches or surpasses the default threshold, the VitalAlert is triggered.
To help improve nursing productivity, Visensia VitalAlert can be programmed to trigger audio or visual alerts at bedside, central station, pagers, phones, and nurse communication systems, the company said.
Frank Cheng, president and CEO of OBS Medical, said: “As confirmed by recently published data from a large-scale clinical study, Visensia VitalAlert can enable a high-precision alerting process resulting in reliable identification of patient crisis.”